Alar Pharmaceuticals Inc. announced the patent, KETAMINE PAMOATE AND USE THEREOF,@ applied by Alar PharmaceuticalsInc. has received notice of allowance from Instituto Mexicano de la Propiedad Industrial (Mexico, IMPI). (Patent Application No.2021006029). Granding above patent by the Company will facilitate the international licensing business.

It takes a considerable time to develop a new drug and the cost of development is relatively high. The success of the development is not guaranteed. The investors shall bear the investment risk and judge the investment with caution.